샘플 요청 목록

 카트 문의
시장보고서
상품코드
2067583

수의학용 체외수정 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 동물별, 방법별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Veterinary In Vitro Fertilization Market Size, Share & Trends Analysis Report By Product, By Animal, By Technique, By End Use, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 9,281,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 10,841,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 13,961,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수의학용 체외수정 시장 개요

세계의 수의용 체외수정 시장 규모는 2025년에 19억 달러로 추계되며, 2033년까지 36억 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 8.2%로 성장할 것으로 전망되고 있습니다.

이 시장의 성장은 유전적으로 우수한 가축에 대한 수요 증가, 소, 말 및 이국적인 품종에 대한 첨단 생식 기술의 도입 확대, 그리고 생산성과 생물 다양성 향상에 기여하는 동물 번식 및 보전 프로그램을 지원하는 정부의 노력에 힘입어 이루어지고 있습니다.

수의학용 체외수정(IVF) 시장은 기술의 발전과 보다 저렴한 제품의 등장으로 크게 성장하고 있습니다. 예를 들어 2024년 9월, Indian Immunologicals Limited는 국립낙농개발위원회(NDDB)와 공동으로 국산 IVF 배지 ‘Shashthi’를 개발했습니다. 이를 통해 수입 배지에 비해 배아 1개당 비용을 33% 절감함으로써, 농가가 더 쉽게 구할 수 있게 되었습니다. 난자 채취(OPU)나 체외 배아 생산(IVEP)과 같은 혁신적인 기술이 기존의 생체내 기술을 대체하며, 가축 배아의 품질 향상과 유전적 다양성 확대에 기여하고 있습니다. 이러한 발전과 더불어 비용 대비 효과가 높은 IVF 솔루션이 이용 가능해짐에 따라 동물병원 및 불임 치료 클리닉에서의 도입이 가속화되고 있으며, 이는 생산성 향상과 보조생식기술의 광범위한 수용을 촉진하고 있습니다.

또한 체외수정의 적용 범위를 가축이나 반려동물에서 야생동물 보전으로 확대함에 따라 시장 수요가 더욱 증가할 것으로 예상됩니다. 또한 수의학적 생식 기술에 대한 투자, 혁신 및 학제 간 연구 촉진으로 이어져, 종 보전 및 지구적 차원의 생물다양성 보전 노력에서 체외수정의 역할이 확고해질 것으로 전망됩니다. 예를 들어 2024년 1월, 독일 라이프니츠 동물원·야생동물 연구소가 주도하는 ‘BioRescue’ 컨소시엄의 과학자들은 남부 흰코뿔소에서 세계 최초로 배아 이식에 성공했습니다. 이는 멸종 위기에 처한 북부 흰코뿔소를 구하기 위한 중요한 이정표가 될 것입니다. 체외수정(IVF)을 통해 보존된 정자와 난자로 만들어진 배아는 현재 독일과 이탈리아에 보관되어 있으며, 케냐의 대리모에게 최초의 북백코뿔소 배아를 이식할 계획이 진행 중입니다. 첫 번째 임신은 조기에 중단되었지만, 이번 성과는 코뿔소의 체외수정 및 배아 이식이 가능함을 입증한 것으로, 대형 포유류의 생식 과학 분야에서 획기적인 진전으로 평가받고 있습니다.

자주 묻는 질문

  • 수의학용 체외수정 시장 규모는 어떻게 예측되나요?
  • 수의학용 체외수정 시장의 성장은 어떤 요인에 의해 이루어지고 있나요?
  • 수의학용 체외수정 기술의 발전은 어떤 영향을 미치고 있나요?
  • 체외수정의 적용 범위는 어떻게 확대되고 있나요?
  • 수의학적 생식 기술에 대한 최근 연구 성과는 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 : 변수, 동향, 범위

제4장 수의학용 체외수정 시장 : 제품별 추정·동향 분석

제5장 수의학용 체외수정 시장 : 동물별 추정·동향 분석

제6장 수의학용 체외수정 시장 : 기술별 추정·동향 분석

제7장 수의학용 체외수정 시장 : 용도별 추정·동향 분석

제8장 수의학용 체외수정 시장 : 지역별 추정·동향 분석

제9장 경쟁 구도

KSA

Veterinary In Vitro Fertilization Market Summary

The global veterinary in vitro fertilization market size was estimated at USD 1.9 billion in 2025 and is projected to reach USD 3.6 billion by 2033, growing at a CAGR of 8.2% from 2026 to 2033. The market is experiencing growth driven by rising demand for genetically superior livestock, increasing adoption of advanced reproductive technologies in cattle, equine, and exotic species, and government initiatives supporting animal breeding and conservation programs, which collectively enhance productivity and biodiversity.

The veterinary in vitro fertilization (IVF) market is being significantly driven by technological advancements and the launch of more affordable products. For instance, in September 2024, Indian Immunologicals Limited, in collaboration with the National Dairy Development Board (NDDB), developed "Shashthi," an indigenous IVF media, reducing the cost per embryo by 33% compared to imported media and enhancing accessibility for farmers. Innovations such as Ovum Pick Up (OPU) and In Vitro Embryo Production (IVEP) are replacing traditional in vivo techniques, improving embryo quality and genetic multiplication in livestock. These advancements, coupled with the availability of cost-effective IVF solutions, are accelerating adoption across veterinary hospitals and fertility clinics, boosting productivity and fostering widespread acceptance of assisted reproductive technologies.

Additionally, expanding the scope of IVF beyond livestock and companion animals into wildlife conservation is expected to boost market demand. It is also expected to drive increased investment, innovation, and cross-disciplinary research in veterinary reproductive technologies, solidifying IVF's role in species preservation and global biodiversity initiatives. For instance, in January 2024, Scientists from the BioRescue consortium, led by Germany's Leibniz Institute for Zoo and Wildlife Research, achieved the world's first successful embryo transfer in southern white rhinos - a major milestone toward saving the nearly extinct northern white rhino. Using IVF, embryos created from preserved sperm and eggs are now stored in Germany and Italy, with plans to implant the first northern white rhino embryo into a surrogate in Kenya. Though the initial pregnancy ended prematurely, the achievement proves that rhino IVF and embryo transfer can work, marking a breakthrough in large-mammal reproduction science.

Global Veterinary In Vitro Fertilization Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary in vitro fertilization market report based on product, animal, technique, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents/Consumables
  • Services
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Bovine
  • Swine
  • Ovine
  • Caprine
  • Equine
  • Other Animals
  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Artificial Insemination
  • Embryo Transfer
  • Ovum Pickup
  • In-Vitro Maturation
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Fertility Clinics
  • Veterinary Hospitals
  • Research Laboratories
  • Cryobanks
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal
    • 1.2.3. Technique
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Bottom-Up Analysis
    • 1.7.2. Model 2: Volume-Pricing Analysis
    • 1.7.3. Model 3: Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for meat, dairy, and animal protein products.
      • 3.2.1.2. Rising demand for advanced reproductive technologies in animal breeding
      • 3.2.1.3. Technological advancements in IVF techniques
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of veterinary IVF services
      • 3.2.2.2. Regulatory, ethical, and skilled-personnel challenges.
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Pricing Analysis
  • 3.4. Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary In Vitro Fertilization Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary In Vitro Fertilization Market, By Product Movement Analysis
  • 4.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reagents/Consumables
    • 4.5.1. Reagents/Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary In Vitro Fertilization Market: Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary In Vitro Fertilization Market, By Animal Movement Analysis
  • 5.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 5.4. Bovine
    • 5.4.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Swine
    • 5.5.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ovine
    • 5.6.1. Ovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Caprine
    • 5.7.1. Caprine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Equine
    • 5.8.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others Animals
    • 5.9.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary In Vitro Fertilization Market: By Technique Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary In Vitro Fertilization Market, By Technique Movement Analysis
  • 6.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, By Technique, 2021 to 2033 (USD Million)
  • 6.4. Artificial Insemination
    • 6.4.1. Artificial Insemination Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Embryo Transfer
    • 6.5.1. Embryo Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ovum Pickup
    • 6.6.1. Ovum Pickup Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. In-Vitro Maturation
    • 6.7.1. In-Vitro Maturation Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary In Vitro Fertilization Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary In Vitro Fertilization Market, By End Use Movement Analysis
  • 7.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Fertility Clinics
      • 7.3.1.1. Veterinary Fertility Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Veterinary Hospitals
      • 7.3.2.1. Veterinary Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Research Laboratories
      • 7.3.3.1. Research Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Cryobanks
      • 7.3.4.1. Cryobanks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Others
      • 7.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary In Vitro Fertilization Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2025 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Netherlands
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Netherlands Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Sweden
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.10. Norway
      • 8.4.10.1. Key Country Dynamics
      • 8.4.10.2. Competitive Scenario
      • 8.4.10.3. Regulatory Framework
      • 8.4.10.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Zoetis Services LLC
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Kruuse
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Hamilton Thorne, Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Esco Medical
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Imy Technologies
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Minitube
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Agetech Inc.
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Orgensen Laboratories
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Bovine Elite LLC
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Equine Fertility Centre
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Veterinary Group
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Stateline Veterinary Service
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
  • 9.4. List of other key players
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기